Clinical Trials Directory

Trials / Unknown

UnknownNCT02847039

Early Repolarization Syndrome: Define the Risk, Stratify the Coverage and Understand the Causes - Clinical and Genetic Study

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The research project aims to try to answer the many questions raised by the identification of new early repolarization syndrome. The questions are varied with both taking optimal clinical management of patients, the frequency and significance of this anomaly in the population on the electrophysiological and molecular basis responsible for this electrocardiographic abnormality. To try to answer these many questions, the approach will be twofold: clinical and genetic. * Establishment of a clinical database containing information of patients who have been identified as carriers of the anomaly based on the initial clinical presentation in order to determine their prognoses. * Physiological approach will be based on a molecular approach to identify genetic abnormalities may be involved in this syndrome. * 200 asymptomatic patients and an unlimited number of patients who presented syncope or aborted sudden death will be included. A blood sample (15 ml) will be performed at inclusion.

Conditions

Interventions

TypeNameDescription
GENETICBlood samplesBlood samples at baseline.

Timeline

Start date
2008-01-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2016-07-27
Last updated
2021-09-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02847039. Inclusion in this directory is not an endorsement.